Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Production of Chlamydia pneumoniae Proteins in Bacillus subtilis and Their Use in Characterizing Immune Responses in the Experimental Infection Model

Production of Chlamydia pneumoniae Proteins in Bacillus subtilis and Their Use in Characterizing... Ulla Airaksinen,1, Tuula Penttilä,2,3 Eva Wahlström,1, Lynda Jackson,1, Jenni M. Vuola,1 Mirja Puolakkainen,2,3 and Matti Sarvas1, * Department of Vaccines, National Public Health Institute,1 Haartman Institute, Department of Virology, University of Helsinki,2 HUCH Laboratory Diagnostics, Division of Virology Helsinki, Finland3 Volume 10, no. 3, p. 367-375, 2003. The article byline should read as given above. Page 367: The following footnote should be added: "Present address: Via Guiseppe Motta 34, CH 6900 Lugano, Ticino, Switzerland." Page 374: The Acknowledgments section should appear as shown below. This work was supported by contracts BIO4-CT96-0152 of the Biotechnology Program, and ERBCHGC930360 of the Capital and Mobility Program (L.J.) of the Commission of the European Union. We acknowledge Leena Liesirova, Outi Rautio, Irene Viinikangas, Saija Kokkoniemi, and Anja Ratilainen for skillful technical assistance. We thank P. Helena Mäkelä for her valuable contribution to the writing of this paper and Juha Heikkilä, University of Lapland, Rovaniemi, Finland, for help with statistical analysis. Clinical and Diagnostic Laboratory Immunology, March 2004, p. 436, Vol. 11, No. 2 1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.2.436.2004 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical and Vaccine Immunology American Society For Microbiology

Production of Chlamydia pneumoniae Proteins in Bacillus subtilis and Their Use in Characterizing Immune Responses in the Experimental Infection Model

Production of Chlamydia pneumoniae Proteins in Bacillus subtilis and Their Use in Characterizing Immune Responses in the Experimental Infection Model

Clinical and Vaccine Immunology , Volume 11 (2): 436 – Mar 1, 2004

Abstract

Ulla Airaksinen,1, Tuula Penttilä,2,3 Eva Wahlström,1, Lynda Jackson,1, Jenni M. Vuola,1 Mirja Puolakkainen,2,3 and Matti Sarvas1, * Department of Vaccines, National Public Health Institute,1 Haartman Institute, Department of Virology, University of Helsinki,2 HUCH Laboratory Diagnostics, Division of Virology Helsinki, Finland3 Volume 10, no. 3, p. 367-375, 2003. The article byline should read as given above. Page 367: The following footnote should be added: "Present address: Via Guiseppe Motta 34, CH 6900 Lugano, Ticino, Switzerland." Page 374: The Acknowledgments section should appear as shown below. This work was supported by contracts BIO4-CT96-0152 of the Biotechnology Program, and ERBCHGC930360 of the Capital and Mobility Program (L.J.) of the Commission of the European Union. We acknowledge Leena Liesirova, Outi Rautio, Irene Viinikangas, Saija Kokkoniemi, and Anja Ratilainen for skillful technical assistance. We thank P. Helena Mäkelä for her valuable contribution to the writing of this paper and Juha Heikkilä, University of Lapland, Rovaniemi, Finland, for help with statistical analysis. Clinical and Diagnostic Laboratory Immunology, March 2004, p. 436, Vol. 11, No. 2 1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.2.436.2004

Loading next page...
 
/lp/american-society-for-microbiology/production-of-chlamydia-pneumoniae-proteins-in-bacillus-subtilis-and-xH7NFE970w

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Society For Microbiology
Copyright
Copyright © 2004 by the American Society For Microbiology.
ISSN
1556-6811
eISSN
1556-6811
DOI
10.1128/CDLI.11.2.436.2004
Publisher site
See Article on Publisher Site

Abstract

Ulla Airaksinen,1, Tuula Penttilä,2,3 Eva Wahlström,1, Lynda Jackson,1, Jenni M. Vuola,1 Mirja Puolakkainen,2,3 and Matti Sarvas1, * Department of Vaccines, National Public Health Institute,1 Haartman Institute, Department of Virology, University of Helsinki,2 HUCH Laboratory Diagnostics, Division of Virology Helsinki, Finland3 Volume 10, no. 3, p. 367-375, 2003. The article byline should read as given above. Page 367: The following footnote should be added: "Present address: Via Guiseppe Motta 34, CH 6900 Lugano, Ticino, Switzerland." Page 374: The Acknowledgments section should appear as shown below. This work was supported by contracts BIO4-CT96-0152 of the Biotechnology Program, and ERBCHGC930360 of the Capital and Mobility Program (L.J.) of the Commission of the European Union. We acknowledge Leena Liesirova, Outi Rautio, Irene Viinikangas, Saija Kokkoniemi, and Anja Ratilainen for skillful technical assistance. We thank P. Helena Mäkelä for her valuable contribution to the writing of this paper and Juha Heikkilä, University of Lapland, Rovaniemi, Finland, for help with statistical analysis. Clinical and Diagnostic Laboratory Immunology, March 2004, p. 436, Vol. 11, No. 2 1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.2.436.2004

Journal

Clinical and Vaccine ImmunologyAmerican Society For Microbiology

Published: Mar 1, 2004

There are no references for this article.